Yen-Nien Liu

Professor, Master Program in Graduate Institute of Cancer Biology and Drug Discovery
Member, TMU Research Center of Cancer Translational Medicine
Joint-Appointment Professor, Ph.D. Program for Cancer Molecular Biology and Drug Discovery

https://orcid.org/0000-0002-3102-8482

Emailliuy@tmu.edu.tw

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Education

2008 Ph.D.( Medical Sciences), Tzu Chi University
2003 M.S. (Human Genetics), Tzu Chi University

Experience

2019- Professor, Master Program in Graduate Institute of Cancer Biology and Drug Discovery, Taipei Medical University
2019- Professor, Graduate Institute of Cancer Biology and Drug Discovery, Taipei Medical University
2018-2019 Associate Professor, Master Program in Graduate Institute of Cancer Biology and Drug Discovery, Taipei Medical University
2017-2018 Visiting Scholar, Department of Pathology, Duke University Medical Center
2016-2019 Associate Professor, Graduate Institute of Cancer Biology and Drug Discovery, Taipei Medical University
2012-2016 Assistant Professor, Graduate Institute of Cancer Biology and Drug Discovery, Taipei Medical University
2009 Post-doctoral Fellow, National Institutes of Health

Awards

2018 Ta-You Wu Memorial Award, Ministry of Science and Technology, Taiwan
2018 Young Researcher Cancer Research Excellence Award, Taiwan Oncology Society, Taiwan
2015 Young Scholar Award, Taipei Medical University, Taiwan
2014 Excellent Research Award, Taipei Medical University, Taiwan
2014 Young Scholar Award, Taipei Medical University, Taiwan
2003 Master Degree Thesis Award, National Science Council, Taiwan

Research Interests

Molecular Cellular Biology
Cancer metastasis
Gene Regulation
Signal Transduction

Fingerprint

Dive into the research topics where Yen-Nien Liu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

12 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots or

2 Active
22 Finished

研究調控MCTP1在前列腺癌細胞神經內分泌分化的作用機轉
Liu, Y.
3/1/21 → 2/28/22
Project: C - Project of Alliance › o - Chi Mei Medical Center
研究PKLR促進前列腺癌神經內分泌分化之代謝途徑及其治療角色(1/3)
Liu, Y.
8/1/20 → 7/1/21
Project: A - Government Institution › b - Ministry of Science and Technology
探討ZBTB46在神經內分泌前列腺癌抗藥性之分子機轉及治療研究
Liu, Y.
1/1/20 → 12/31/20
Project: A - Government Institution › a - National Health Research Institutes
探討ZBTB46在神經內分泌前列腺癌抗藥性之分子機轉及治療研究(優秀資深研究助理獎助)
Liu, Y.
1/1/20 → 12/1/20
Project: A - Government Institution › a - National Health Research Institutes
A Novel Lifr Axis in Metabolism Unhinged and Neuroendocrine Differentiation of Prostate Cancer(2/3)
Liu, Y.
8/1/19 → 7/31/20
Project: A - Government Institution › b - Ministry of Science and Technology

1372 Citations
19 h-Index
36 Article
3 Comment/debate
2 Review article
1 Paper
More
- 1 Editorial

Nerve growth factor interacts with CHRM4 and promotes neuroendocrine differentiation of prostate cancer and castration resistance
Chen, W. Y., Wen, Y. C., Lin, S. R., Yeh, H. L., Jiang, K. C., Chen, W. H., Lin, Y. S., Zhang, Q., Liew, P. L., Hsiao, M., Huang, J. & Liu, Y. N., Dec 2021, In: Communications Biology. 4, 1, 22.
Research output: Contribution to journal › Article › peer-review

Open Access
Correction: ZBTB46, SPDEF, ETV6 novel potential biomarkers and therapeutic targets in castration resistance prostate cancer (Int. j. mol. sci. (2019), 20, 2802, 10.3390/ijms20112802)
Fararjeh, A. F. S. & Liu, Y. N., Jun 2 2020, In: International journal of molecular sciences. 21, 12, 1 p., 4243.
Research output: Contribution to journal › Comment/debate › peer-review

Open Access
EGFR-upregulated LIFR promotes SUCLG2-dependent castration resistance and neuroendocrine differentiation of prostate cancer
Lin, S. R., Wen, Y. C., Yeh, H. L., Jiang, K. C., Chen, W. H., Mokgautsi, N., Huang, J., Chen, W. Y. & Liu, Y. N., Oct 29 2020, In: Oncogene. 39, 44, p. 6757-6775 19 p.
Research output: Contribution to journal › Article › peer-review
2 Citations (Scopus)
Ras and Wnt interaction contribute in prostate cancer bone metastasis
Lin, S. R., Mokgautsi, N. & Liu, Y. N., May 2020, In: Molecules. 25, 10, 2380.
Research output: Contribution to journal › Review article › peer-review

Open Access
3 Citations (Scopus)
Androgen deprivation-induced ZBTB46-PTGS1 signaling promotes neuroendocrine differentiation of prostate cancer
Chen, W. Y., Zeng, T., Wen, Y. C., Yeh, H. L., Jiang, K. C., Chen, W. H., Zhang, Q., Huang, J. & Liu, Y. N., Jan 1 2019, In: Cancer Letters. 440-441, p. 35-46 12 p.
Research output: Contribution to journal › Article › peer-review
10 Citations (Scopus)

Disruption of ETV6 leads to TWIST1-dependent progression and resistance to epidermal growth factor receptor tyrosine kinase inhibitors in prostate cancer
Tsai, Y. (Contributor), Zeng, T. (Contributor), Abou-Kheir, W. (Contributor), Yeh, H. (Contributor), Yin, J. (Contributor), Lee, Y. (Contributor), Chen, W. (Contributor) & Liu, Y. (Contributor), Unknown Publisher, Feb 19 2018
DOI: 10.6084/m9.figshare.c.4008787.v1, https://figshare.com/collections/Disruption_of_ETV6_leads_to_TWIST1-dependent_progression_and_resistance_to_epidermal_growth_factor_receptor_tyrosine_kinase_inhibitors_in_prostate_cancer/4008787/1
Dataset
Additional file 1: of Disruption of ETV6 leads to TWIST1-dependent progression and resistance to epidermal growth factor receptor tyrosine kinase inhibitors in prostate cancer
Tsai, Y. (Contributor), Zeng, T. (Contributor), Abou-Kheir, W. (Contributor), Yeh, H. (Contributor), Yin, J. (Contributor), Lee, Y. (Contributor), Chen, W. (Contributor) & Liu, Y. (Contributor), Unknown Publisher, Feb 19 2018
DOI: 10.6084/m9.figshare.5900626.v1, https://springernature.figshare.com/articles/Additional_file_1_of_Disruption_of_ETV6_leads_to_TWIST1-dependent_progression_and_resistance_to_epidermal_growth_factor_receptor_tyrosine_kinase_inhibitors_in_prostate_cancer/5900626/1
Dataset